The initial steps leading to papillomavirus infection occur on the basement membrane prior to cell surface binding

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 48, 2009, Pages 20458-20463

  Kines, Rhonda C ^a   Thompson, Cynthia D ^a   Lowy, Douglas R ^a   Schiller, John T ^a   Day, Patricia M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Furin; HSPG; Mouse model; Proprotein convertase

Indexed keywords

EPITOPE; FURIN; HEPARIN LYASE; PROPROTEIN CONVERTASE 1; PROTEOHEPARAN SULFATE;

ARTICLE; BASEMENT MEMBRANE; CELL MIGRATION; CELL SURFACE; CONFORMATION; KERATINOCYTE; NONHUMAN; PAPILLOMA VIRUS; PRIORITY JOURNAL; VIRION; VIRUS ATTACHMENT; VIRUS CAPSID; VIRUS INFECTION; VIRUS INFECTIVITY;

ANIMALS; BASEMENT MEMBRANE; CAPSID PROTEINS; FEMALE; FURIN; HEPARAN SULFATE PROTEOGLYCANS; KERATINOCYTES; MICE; MICE, INBRED BALB C; MICROSCOPY, FLUORESCENCE; MODELS, BIOLOGICAL; PAPILLOMAVIRUS INFECTIONS; VAGINA; VIRUS ATTACHMENT;

HUMAN PAPILLOMAVIRUS; MIRIDAE; MURINAE; PAPILLOMAVIRIDAE;

EID: 73949127173     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0908502106     Document Type: Article

References (27)

1. Friedewald W (1942) Cell State as affecting susceptibility to a virus: Enhanced effectiveness of the rabbit papilloma virus on hyperplastic epidermis. J Exp Med 75:197-220.
2. Lacey M, Alpert S, Hanahan D (1986) Bovine papillomavirus genome elicits skin tumours in transgenic mice. Nature 322:609-612.
3. Auewarakul P, Gissmann L, Cid-Arregui A (1994) Targeted expression of the E6 and E7 oncogenes of human papillomavirus type 16 in the epidermis of transgenic mice elicits generalized epidermal hyperplasia involving autocrine factors. Mol Cell Biol 14:8250-8258.
4. CladelNM,Hu J, Balogh K, Mejia A, ChristensenND(2008)Woundingprior to challenge substantially improves infectivity of cottontail rabbit papillomavirus and allows for standardization of infection. J Virol Methods 148:34-39.
5. Roberts JN, et al. (2007) Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan. Nat Med 13:857-861.
6. Johnson KM, et al. (2009) Role of heparan sulfate in attachment to and infection of the murine female genital tract by human papillomavirus. J Virol 83:2067-2074.
7. Buck CB, Thompson CD (2007) Production of papillomavirus-based gene transfer vectors. Curr Protoc Cell Biol Ch 26:Unit 26 21.
8. Selinka HC, et al. (2007) Inhibition of transfer to secondary receptors by heparan sulfate-binding drug or antibody induces noninfectious uptake of human papillomavirus. J Virol 81:10970-10980.
9. Day PM, Lowy DR, Schiller JT (2008) Heparan sulfate-independent cell binding and infection with furin pre-cleaved papillomavirus capsids. J Virol 82:12565-12568.
10. Richards RM, Lowy DR, Schiller JT, DayPM(2006) Cleavage of the papillomavirus minor capsid protein, L2, at a furin consensus site is necessary for infection. Proc Natl Acad Sci USA 103:1522-1527.
11. Day PM, Gambhira R, Roden RB, Lowy DR, Schiller JT (2008) Mechanisms of human papillomavirus type 16 neutralization by L2 cross-neutralizing and L1 type-specific antibodies. J Virol 82:4638-4646.
12. Plaimauer B, et al. (2001) 'Shed' furin: Mapping of the cleavage determinants and identification of its C-terminus. Biochem J 354:689-695.
13. Denault J, et al. (2002) Ectodomain shedding of furin: Kinetics and role of the cysteinerich region. FEBS Lett 527:309-314.
14. Blanpain C, Fuchs E (2006) Epidermal stem cells of the skin. Annu Rev Cell Dev Biol 22:339-373.
15. Pyeon D, Pearce SM, Lank SM, Ahlquist P, Lambert PF (2009) Establishment of human papillomavirus infection requires cell cycle progression. PLoS Pathog 5:e1000318.
16. Sivamani RK, Lam ST, Isseroff RR (2007) Beta adrenergic receptors in keratinocytes. Dermatol Clin 25:643-653.
17. Mayer G, et al. (2008) The regulated cell surface zymogen activation of the proprotein convertase PC5A directs the processing of its secretory substrates. J Biol Chem 283:2373-2384.
18. Culp TD, Budgeon LR, Christensen ND (2006) Human papillomaviruses bind a basal extracellular matrix component secreted by keratinocytes which is distinct from a membrane-associated receptor. Virology 347:147-159.
19. Culp TD, Budgeon LR, Marinkovich MP, Meneguzzi G, Christensen ND (2006) Keratinocyte-secreted laminin 5 can function as a transient receptor for human papillomaviruses by binding virions and transferring them to adjacent cells. J Virol 80:8940-8950.
20. Day PM, et al. (2007) Neutralization of human papillomavirus with monoclonal anti-bodies reveals different mechanisms of inhibition. J Virol 81:8784-8792.
21. Jagu S, et al. (2009) Concatenated multitype L2 fusion proteins as candidate prophylactic pan-human papillomavirus vaccines. J Natl Cancer Inst 101:782-792.
22. Roden RB, et al. (2000) Minor capsid protein of human genital papillomaviruses contains subdominant, cross-neutralizing epitopes. Virology 270:254-257.
23. Yaegashi N, Jenison SA, Batra M, Galloway DA (1992) Human antibodies recognize multiple distinct type-specific and cross-reactive regions of the minor capsid proteins of human papillomavirus types 6 and 11. J Virol 66:2008-2019.
24. Chandrachud LM, et al. (1995) Vaccination of cattle with the N-terminus of L2 is necessary and sufficient for preventing infection by bovine papillomavirus-4. Virology 211:204-208.
25. Golding H, et al. (2002) Dissection of human immunodeficiency virus type 1 entry with neutralizing antibodies to gp41 fusion intermediates. J Virol 76:6780-6790.
26. Roden RB, et al. (1996) In vitro generation and type-specific neutralization of a human papillomavirus type 16 virion pseudotype. J Virol 70:5875-5883.
27. Gambhira R, et al. (2007)Aprotective and broadly cross-neutralizing epitope ofhuman papillomavirus L2. J Virol 81:13927-13931.